#USA #New York #Pomerantz Law #Reckitt Benckiser #RBGLY

Pomerantz Law Firm Takes Action Against Reckitt Benckiser Group

On June 7, 2025, Pomerantz LLP announced the initiation of a class action lawsuit against Reckitt Benckiser Group Plc (OTC: RBGLY) in response to claims of securities fraud and unlawful business practices. This legal move is critical for investors who may have incurred substantial losses in their investments with Reckitt.

Investors are encouraged to get in touch with Danielle Peyton via email ([email protected]) or by dialing 646-581-9980 to determine their eligibility for participation in this class action. To streamline the process, those who connect via email should include their mailing addresses, contact numbers, and the number of shares they have purchased.

The class action lawsuit revolves around allegations that Reckitt and its executives might have engaged in deceptive practices that misled investors. If you acquired Reckitt securities during the class period, you have until August 4, 2025 to petition the court to appoint you as Lead Plaintiff. Access to the official Complaint can be found at www.pomerantzlaw.com.

Background of the Case

This legal action isn’t the first instance in which Reckitt has found itself in troubled waters. On March 15, 2024, a jury in Illinois delivered a $60 million verdict against Reckitt's subsidiary, Mead Johnson, for its failure to appropriately warn consumers that its cow's milk-based baby formula could increase the risk of necrotizing enterocolitis (NEC) among premature infants. As a result, Reckitt’s stock price saw a significant decline of 14%, dropping $1.87 to close at $11.44 on the same day.

In a similar vein, on July 29, 2024, a Missouri jury awarded $495 million in a lawsuit involving Abbott Laboratories, which found parallels with Reckitt's situation about NEC. Following this verdict, Reckitt's American Depositary Share (ADS) fell again by 9%, closing at $10.64.

The Role of Pomerantz LLP

Pomerantz LLP is noted as one of the leading legal firms specializing in corporate, securities, and antitrust class litigation worldwide. It has maintained this prestigious standing for over 85 years, having been established by Abraham L. Pomerantz, who is recognized as a pioneer in the field of class action securities lawsuits. The firm has a solid track record of recovering enormous financial compensation for class members affected by corporate malfeasance and fiduciary violations.

While the journey for investors grappling with losses in this case may appear daunting, engaging with the Pomerantz team could provide a viable pathway to seek recompense. Investors who faced losses are strongly recommended to stay informed and act quickly given the looming deadline.

Conclusion

Understanding your rights as an investor is crucial, especially in the midst of legal proceedings such as this class action lawsuit against Reckitt Benckiser Group. By staying vigilant and taking necessary actions, you may recover some of your losses. For more information about the class action, potential outcomes, and to consider involvement as a lead plaintiff, please visit the Pomerantz website or reach out to them directly.